Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen.

Autor:	Zhu, Xiaoqin, Zhu, Jia, Sun, Feifei, Zhen, Zijun, Zhou, Dalei, Lu, Suying, Huang, Junting, Que, Yi, Zhang, Lian, Cai, Ruiqing, Wang, Juan, Zhang, Yizhuo
Předmět:	CHILD patients PHARMACOGENOMICS TUMOR lysis syndrome TUMORS DRUG side effects IRINOTECAN
Zdroj:	Pharmacogenomics & Personalized Medicine; Mar2021, Vol. 14, p369-377, 9p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu